| Summary: | Background: Due to the emergence of multidrug resistant microorganisms, new classes of antibiotics are needed. In this paper, we present the cytotoxic effects of five tricyclic flavonoids, one of which was previously identified as a potent antimicrobial agent. Methods: All five derivatives were tested against human HOS and MCF7 cancer cell lines using a wound scratch assay. The cytotoxic properties of previously reported flavonoid <b>4a</b> were also evaluated using the standard MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium, inner salt) and live/dead assays, using NHDF, HOS and MCF7 cell lines. Results: All five derivatives were found to inhibit to some degree the proliferation of cancer cells. <b>4a</b> was also found to be less toxic towards regular versus cancerous human cells. Moreover, the minimum bactericidal concentration of <b>4a</b> against <i>Staphylococcus aureus</i> was found to be non-toxic for any of the tested human cell lines. Conclusions: Derivative <b>4a</b> has the potential of being used as a therapeutic agent against certain microorganisms. Further structure optimization is required for use against tumors.
|
|---|